| Date Filed | Type | Description |
| 09/29/2023 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 08/15/2023 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 300 shares
@ $2.875, valued at
$862.5 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Exercised 139 shares
@ $2.4, valued at
$333.6
Exercised 139 options to buy
@ $0 |
|
| 09/30/2022 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 23,500 options to buy
@ $12.62, valued at
$296.6k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4/A
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 139 options to buy
@ $2.4, valued at
$333.6
Granted 139 options to buy
@ $17.7, valued at
$2.5k
|
|
| 01/26/2022 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Exercised 70 shares
@ $2.4, valued at
$168
Exercised 70 options to buy
@ $0 |
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Exercised 70 shares
@ $2.4, valued at
$168
Exercised 70 options to buy
@ $0 |
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2020 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Exercised 60 shares
@ $2.4, valued at
$144
Exercised 60 options to buy
@ $0 |
|
| 10/16/2020 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Exercised 16,850 options to buy
@ $0 |
|
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.6, valued at
$52k
|
|
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2017 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 20,777 shares
@ $0
Granted 4,755 options to buy
@ $0.08, valued at
$380.4
Granted 1,791 options to buy
@ $0.08, valued at
$143.3
Granted 2,090 options to buy
@ $0.08, valued at
$167.2
Granted 4,178 options to buy
@ $0.08, valued at
$334.2
Granted 4,177 options to buy
@ $0.59, valued at
$2.5k
|
|
| 05/08/2017 |
3
| Drutz David (Director) has filed a Form 3 on Altimmune, Inc. |
| 12/07/2015 |
4
| Drutz David (Executive Chairman and CMO) has filed a Form 4 on Midatech Pharma US Inc.|
Txns:
| Disposed/sold 20,614 shares
@ $0
Disposed/sold 375 options
@ $36, valued at
$13.5k
Disposed/sold 1,000 options
@ $15.15, valued at
$15.2k
Disposed/sold 2,000 options
@ $10.25, valued at
$20.5k
Disposed/sold 75,000 options
@ $6.55, valued at
$491.3k
Disposed/sold 10,000 options
@ $5, valued at
$50k
Disposed/sold 43,333 options
@ $5, valued at
$216.7k
Disposed/sold 80,000 options
@ $5.05, valued at
$404k
Disposed/sold 100,000 options
@ $2.9, valued at
$290k
Disposed/sold 371,000 options
@ $0.79, valued at
$293.1k
Disposed/sold 80,000 options
@ $0.69, valued at
$55.2k
|
|
| 05/20/2015 |
4
| Drutz David (Executive Chairman and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.69, valued at
$55.2k
|
|
| 02/09/2015 |
4
| Drutz David (Executive Chairman and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Granted 371,000 options to buy
@ $0.79, valued at
$293.1k
|
|
| 06/05/2014 |
4
| Drutz David (CEO and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Bought 50 options to buy
@ $0
Bought 22,523 options to buy
@ $1.67, valued at
$37.6k
|
|
| 03/06/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/20/2013 |
4
| Drutz David (CEO and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Bought 25,000 shares
@ $0.6976, valued at
$17.4k
|
|
| 03/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2013 |
4
| Drutz David (CEO and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Granted 216,666 options to buy
@ $1, valued at
$216.7k
|
|
| 09/17/2012 |
4
| Drutz David (CEO and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Bought 25,000 shares
@ $1.06, valued at
$26.5k
|
|
| 06/11/2012 |
4
| Drutz David (CEO and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Bought 25,000 shares
@ $0.77, valued at
$19.3k
|
|
| 05/30/2012 |
4
| Drutz David (CEO and CMO) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Bought 25,000 shares
@ $0.9013, valued at
$22.5k
|
|
| 05/17/2012 |
4
| Drutz David (Director) has filed a Form 4 on DARA BioSciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1, valued at
$50k
|
|
| 01/30/2012 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|